Home > Products > HER3 & IGF1R
> Anti-HER3 x Anti-IGF1R Bispecific Antibody (IgG-IgG)
Anti-HER3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) (CAT#: BSIG-169)
Anti-HER3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-HER3 and anti-IGF1R parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Pancreatic cancer; Hepatocellular carcinoma (HCC) therapy.
There are currently no customer reviews or questions for Anti-HER3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) (BSIG-169). Click the button below to contact us or submit your feedback about this product.